MONROVIA, CA, February 18, 2013
/24-7PressRelease/ -- Douglas A. Melton will give a keynote presentation on "How To Make Pancreatic Beta Cells" at the Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston MA).
Dr. Melton's presentation will focus on the research of making human pancreatic beta cells to study and treat diabetes. This goal is pursued with two main approaches: directing the differentiation of stem cells into beta cells and studying the signals that replicate pre-existing beta cells. The signals that direct stem and progenitor cells toward a mature beta cell phenotype will be described as well as work on a secreted protein, betatrophin, that induces beta cell replication.
Dr. Melton is the Xander University Professor at Harvard University and an investigator at the Howard Hughes Medical Institute. Dr. Melton serves as the co-director of the Harvard Stem Cell Institute, co-chairs the Harvard University Department of Stem Cell and Regenerative Biology and serves on the Scientific Advisory Board of the Genetics Policy Institute. He holds membership in the National Academy of the Sciences, and is a founding member of the International Society for Stem Cell Research. Melton's early work in the 1980s pioneered the technique of in vitro transcription. His current research interests include pancreatic developmental biology and the directed differentiation of human embryonic stem cells, particularly in pertinence to type 1 diabetes.
Douglas A. Melton will join over 45 experts from the industry, academia and government at the Stem Cell Summit 2013 to discuss recent developments in stem cell research. Experts will discuss pre-clinical and clinical trials of stem cell therapy, regenerative medicine, tissue engineering, cancer stem cells, stem cell reprogramming, new paradigms for drug discovery/cell therapy and regulatory policies. Experts will also discuss other important stem cell issues such business opportunities, challenges in commercialization and the potential strategies for overcoming these challenges.
Track A: Stem Cell Research & Regenerative Medicine:
Joint Session: Funding Opportunities
Joint Session: Regulatory Guidance & Updates
Session: Advances in iPS & ES Cells
Session: Advances in Adult Stem Cells
Session: New Paradigms for Cell Therapy
Track B: Stem Cell Commercialization & Partnering:
Joint Session: Funding Opportunities
Joint Session: Regulatory Guidance & Update
Session: Novel Technologies in Stem Cell Research
Session: Overcoming Challenges in Clinical Development
Session: Commercialization: Bringing Therapeutics to Market
Session: Partnerships & Acquisitions
Summit Agenda: http://www.gtcbio.com/stemcellsummit/agenda
Summit Speaker List: http://www.gtcbio.com/stemcellsummit/speakers
For more information, please visit http://www.gtcbio.com
GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTC (Global Technology Community), LLC, is a privately held company founded in 2002.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Read more Press Releases from Kristen Starkey:
